6 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
-2 inhibitors - ... Canagliflozin ( ... Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... CANVAS - Canagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology Summary ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... #Summary #DM2 #
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic ... Acetazolamide, others SGLT2 ... INHIBITORS • ... Canagliflozin ... • Dapagliflozin,
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... SGLT2 inhibitors ... treatment of type II diabetes ... (Invokana®), dapagliflozin ... , #dapagliflozin
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... Improved outcomes in CKD